Dongseongro Rosuvastatin Tablet 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium
Prescription medication
Dongseong Pharmaceutical Co., Ltd.
MFDS item code 201803584 · Approved 2018.09.03
This product's status changed to Expired on 2023.09.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used to help patients with primary hypercholesterolemia and mixed dyslipidemia who are not adequately controlled by diet and exercise. It is also used as an adjunct treatment for patients with homozygous familial hypercholesterolemia, in conjunction with dietary therapy or LDL apheresis. It effectively lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It is recommended as an adjunct to diet for pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia who meet specific criteria. It is beneficial in treating primary dysbetalipoproteinemia and is used to reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures in middle-aged patients with a high risk of cardiovascular disease. Overall, this medication contributes to improving cardiovascular health and lowering the risk of related complications.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and should continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients who are allergic to any component of this drug, have severe liver dysfunction, have muscle disorders, have severe kidney impairment, or are pregnant or breastfeeding should not take this medication. Additionally, as this medication can affect muscles, symptoms such as muscle pain or myopathy may occur, so patients at high risk for muscle-related diseases should use it with caution. If symptoms such as muscle pain, weakness, or fever occur during treatment, immediate consultation with a physician is necessary. It can affect liver function, so patients with a history of liver disease or those who consume alcohol excessively should undergo regular liver function tests before and after taking this medication. This medication contains lactose, so patients with lactose intolerance should not take it, and caution is required for patients with certain genetic disorders. This medication can interact with other drugs, so it is advisable to consult a physician or pharmacist, especially when taken with drugs with a high risk of muscle toxicity. Concomitant use with certain medications may increase the blood concentration of this medication, raising the risk of side effects. Women who may become pregnant should use appropriate contraception during treatment and should stop taking the medication immediately if they become pregnant. There is no specific antidote in the case of overdose, so treatment according to symptoms and liver function and muscle enzyme tests are required. Lastly, this medication has been rarely reported to cause serious skin reactions, liver damage, or kidney abnormalities, so if such symptoms occur, immediate notification of healthcare personnel is essential. Caution should be taken as dizziness may occur when driving or operating machinery.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, cough, shortness of breath, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, at a temperature between 1°C and 30°C. This helps maintain the drug's efficacy and prevents deterioration.
Pink round film-coated tablet
30 tablets (15 tablets/PTP(AluAlu)×2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium
Prescription medication
Dongseong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.